AstraZeneca has announced significant reductions for medications sold in the United States, following an agreement made with the Trump administration.
Ana-Maria Tapescu
International
Foto: Formatoriginal / Alamy / Profimedia
Always see our news on Google
President Trump emphasized that, alongside reducing prices, the company will invest 50 billion USD in the USA for research and development, as well as in relocating production. This comes in the context of measures aimed at encouraging pharmaceutical laboratories to repatriate production and reduce prices.
Sources
Administraţia Trump a încheiat un acord cu AstraZeneca pentru reducerea preţului anumitor medicamente
AstraZeneca makes deal with Trump to lower drug prices and avoid tariffs
Trump reveals prescription drug deal with pharmaceutical giant AstraZeneca
AstraZeneca agrees to lower drug prices for Medicaid under Trump administration deal
Trump to announce deal with pharma giant AstraZeneca to lower drug prices, report says.
Latest News
11:39
The USA, South Korea, and Japan will conduct a joint military exercise to test preparedness against nuclear threats from North Korea.
11:36
Romania could have a new designated prime minister by the end of next week / What would be Nicușor Dan's preferred scenario
11:30
Washington is asking NATO allies for written contributions for the assessment of the presence of American troops in Europe.
11:25
Canadian Prime Minister Mark Carney stated that Lake Ontario "will keep its name 'today and forever'", despite Donald Trump's decree.
11:09
Key alert record in Kiev: 13 air alerts were recorded in a single day. The capital of Ukraine was under air siege for 872 minutes.
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
German companies have reduced direct investments in the USA by almost two-thirds in the first half of 2026
.webp)
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
